CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Clinical trials for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nerve shield: could a natural compound stop Chemo's painful side effect?
Prevention TerminatedThis study tests whether a natural substance called GM1 can prevent or reduce nerve damage (pain, numbness, tingling in hands and feet) caused by the chemotherapy drug paclitaxel in people with metastatic breast cancer. About 98 participants will receive either GM1 or a placebo a…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated May 26, 2026 03:09 UTC
-
Exercise program aims to ease chemo nerve damage
Symptom relief OngoingThis study tests a 10-week, at-home exercise program for cancer survivors who have lasting nerve pain, numbness, or tingling from chemotherapy. Researchers want to see if the program is safe, doable, and helpful. Participants will exercise remotely, get health coaching calls, and…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 26, 2026 03:13 UTC
-
Can a natural compound soothe chemo nerve damage?
Symptom relief OngoingThis study tests whether a natural supplement called PEA can reduce nerve pain, numbness, and tingling caused by chemotherapy in cancer patients. About 88 adults who have had these symptoms for at least 3 months will take PEA or a placebo for 8 weeks. The goal is to see if PEA im…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Symptom relief
Last updated May 26, 2026 03:03 UTC
-
Can acupuncture soothe Chemo's nerve damage? new trial aims to find out
Symptom relief OngoingThis study tests whether acupuncture can reduce nerve pain caused by chemotherapy in cancer survivors. About 255 people who have finished chemo will receive either real or sham acupuncture. The goal is to see if this drug-free approach can ease pain and improve daily life.
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Exercise may ease chemo nerve damage in cancer survivors
Symptom relief OngoingThis study looks at whether exercise can reduce nerve damage symptoms caused by chemotherapy, like pain, numbness, or tingling in hands and feet. About 133 cancer patients who had nerve-damaging chemo in the past 9 months will either exercise or receive standard drug treatment. T…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: University of Rochester NCORP Research Base • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Glove trick may shield breast cancer patients from chemo nerve pain
Symptom relief OngoingThis study tests if wearing surgical gloves during paclitaxel chemotherapy can prevent nerve damage (peripheral neuropathy) in breast cancer patients. About 104 people with stage II-III breast cancer will be randomly assigned to wear gloves or not. Researchers will compare change…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Young-Joon Kang • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC
-
Yoga vs. nerve pain: new study tests if stretching beats medication
Symptom relief OngoingThis study tests whether yoga can reduce nerve pain caused by chemotherapy in cancer survivors. About 227 adults who finished chemo at least three months ago will either take yoga classes, attend educational sessions, or receive standard pain care. Researchers will compare pain l…
Matched conditions: CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC